Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2216-2222

  Ogawa, Makoto ^a   Tsutsui, Tateki ^a   Zou, Jian Ping ^a   Mu, Jie ^a   Wijesuriya, Rishani ^a   Yu, Wen Gong ^a   Herrmann, Steven ^b   Kubo, Takeshi ^a   Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER REGRESSION; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; CELL MOVEMENT; FEMALE; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-12; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTORS, LYMPHOCYTE HOMING; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031001042     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Trinchieri, G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood, 84: 4008-4027, 1994.
2. Brunda, M. J. Interleukin-12. J. Leukocyte Biol., 55: 280-288, 1994.
3. Kobayashi, M. Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170: 827-845, 1989.
4. Stern, A. S., Podlaski, F. J., Hulmes, J. D., Pan, Y. C., Quinn, P. M., Wolitzky, A. G., Familletti, P. C., Stremlo, D. L., Truitt, T., Chizzonite, R., and Gately, M. K. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA, 87: 6808-6812, 1990.
5. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H., and Ritz, J. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med., 175: 779-788, 1992.
6. Gately, M. K., Desai, B. B., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., Podlaski, F. J., Familletti, P. C., Sinigaglia, F., Chizzonite, R., Gubler, U., and Stern, A. S. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol., 147: 874-882, 1991.
7. Perussia, B., Chan, S. H., D'Andrea, A., Tsuji, K., Santoli, D., Pospisil, M., Young, D., Wolf, S. F., and Trinchieri, G. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta +, TCR-gamma delta+ T lymphocytes, and NK cells. J. Immunol., 149: 3495-3502, 1992.
8. S. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., and Trinchieri, G. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med., 173: 869-879, 1991.
9. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., and Romagnani, S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Thl)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med., 177: 1199-1204, 1993.
10. Yanagida, T., Kalo, T., Igarashi, O., Inoue, T., and Nariuchi, H. Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone. J. Immunol. ,152: 4919-4928, 1994.
11. Germann, T., Gately, M. K., Schoenhaut, D. S., Lohoff, M., Mattner, F., Fischer, S., Jin, S. C., Schmitt, E., and Rude, E. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Thl) but not on Th2 cells. Eur. J. Immunol., 23: 1762-1770, 1993.
12. Allavena, P., Paganin, C., Zhou, D., Bianchi, G., Sozzani, S., and Mantovani, A. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood, 84: 2261-2268, 1994.
13. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., and Lotze, M. T. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol., 153: 1697-1706, 1994.
14. Zou, J. P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. Int. Immunol., 7: 1135-1145, 1995.
15. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
16. Brunda, M. J., Luistro, L., Handrzak, J. A., Fountoulakis, M., Garotta, G., and Gately, M. K. Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J. Immunother., 17: 71-77, 1995.
17. Yu, W-G., Yamamoto, N., Takenaka, H., Mu, J., Tai, X-G., Zou, J-P., Ogawa, M., Tsutsui, T., Wijesuriya, R., Yoshida, R., Herrmann, S., Fujiwara, H., and Hamaoka, T. Molecular mechanism underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int. Immunol., 8: 855-865, 1996.
18. Yoshida, T. O., Haraguchi, S., Miyamoto, H., and Matsuo, T. Recognition of RSV-induced tumor cells in syngenic mice and semisyngeneic reciprocal hybrid mice. Gann Monogr. Cancer Res., 23: 201-212, 1979.
19. Mu, J., Zou, J. P., Yamamoto, N., Tsutsui, T., Tai, X. G., Kobayashi, M., Herrmann, S., Fujiwara, H., and Hamaoka, T. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res., 55: 4404-4408, 1995.
20. Ogata, M., Shimizu, J., Kosaka, H., Maekawa, R., Shimizu, K., Fujiwara, H., and Hamaoka, T. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas. Jpn. J. Cancer Res., 77: 1134-1141, 1986.
21. Weston, S. A., and Parish, C. R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods, 133: 87-97, 1990.
22. Zou, J. P., Shimizu, J., Ikegame, K., Yamamoto, N., Ono, S., Fujiwara, H., and Hamaoka, T. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. J. Immunol., 148: 648-655, 1992.
23. Brunda, M. J., Sulich, V., and Bellantoni, D. The anti-tumor effect of recombinant Interferon alpha or gamma is influenced by tumor location. Int. J. Cancer, 40: 807-810, 1987.
24. Truitt, G. A., Bontempo, J. M., Stern, L. L., Sulich, V., Bellantoni, D., Trown, P. W., and Brunda, M. J. Efficacy and toxicity elicited by recombinant interferons alpha and gamma when administered in combination to tumor-bearing mice. Biotechnol. Ther., 1: 1-16, 1989.
25. Cantell, K., Fiers, W., Hirvonen, S., and Pyhala, L. Circulating interferon in rabbits after simultaneous intramuscular administration of human alpha and gamma interferons. J. Interferon Res., 4: 291-293, 1984.
26. Watanabe, Y., Kuribayashi, K., Miyatake, S., Nishihara, K., Nakayama, E., Taniyama, T., and Sakata, T. Exogenous expression of mouse Interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 86: 9456-9460, 1989.
27. Gansbacher, B., Bannerji, R., Daniels, B., Zier, K., Cronin, K., and Gilboa, E. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res., 50: 7820-7825, 1990.
28. Scheynius, A., Camp, R. L., and Pure, E. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol., 150: 655-663, 1993.
29. Kawasaki, K., Yaoita, E., Yamamoto, T., Tamatani, T., Miyasaka, M., and Kihara, I. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J. Immunol., 150: 1074-1083, 1993.
30. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., and Karin, N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (Lond.), 356: 63-66, 1992.
31. + T cells to sites of infection. J. Immunol., 154: 5293-5301, 1995.
32. Yang, X. D., Michie, S. A., Tisch, R., Karin, N., Steinman, L., and McDevitt, H. O. A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA, 91: 12604-12608, 1994.
33. Shimizu, Y., Newman, W., Tanaka, Y., and Shaw, S. Lymphocyte interactions with endothelial cells. Immunol. Today, 13: 106-112, 1992.
34. Salmi, M., Grenman, R., Grenman, S., Nordman, E., and Jalkanen, S. Tumor endothelium selectively supports binding of IL-2-propagated tumor-infiltrating lymphocytes. J. Immunol., 154: 6002-6012, 1995.
35. Shimizu, J., Zou, J. P., Ikegame, K., Katagiri, T., Fujiwara, H., and Hamaoka, T. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts. J. Immunol. ,146: 1708-1714, 1991.
36. Piali, L., Fichtel, A., Terpe, H. J., Imhof, B. A., and Gisler, R. H. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. Exp. Med., 181: 811-816, 1995.